NCI Leadership Presentation
The meeting’s Opening Session took place from 9:30 a.m. to 12:00 p.m. on Saturday, June 4.
During this session, NCI Acting Director Douglas R. Lowy, M.D., presented the NCI Director’s Address (about 10:25–10:40 a.m.). The session followed the theme of the meeting, Advancing Equitable Cancer Care Through Innovation.
Cancer Research Opportunities, Funding, and Progress
NCI Experts Participating in Panel Sessions
NCI experts joined their colleagues across the field of clinical oncology to participate in panel discussions during the meeting. View the presentation links for more information about each session.
| Panel Title | NCI Presenter | Date and Time |
|---|---|---|
|
Andrea B. Apolo, M.D. |
Friday, June 3 at 1:00 p.m. |
|
|
Biomarkers for Screening, Diagnosis, Monitoring, and Surveillance of Head and Neck Cancers |
Anil Chaturvedi, Ph.D. |
Friday, June 3 at 1:00 p.m. |
|
Ramaprasad Srinivasan, M.D., Ph.D. |
Friday, June 3 at 1:00 p.m. |
|
|
ASCO Town Hall: The Future of the Conduct of Clinical Trials After COVID-19 |
Margaret M. Mooney, M.D. |
Saturday, June 4 at 3:00 p.m. |
|
Mentorship and Career Development Roundtable: A Discussion with ASCO’s Special Award Recipients |
Ophira Ginsburg, M.D., F.R.C.P.C., M.Sc. |
Saturday, June 4 at 1:15 p.m. |
|
Less Is More: Practical De-Implementation Science Strategies to Improve Quality |
Wynne Norton, Ph.D. |
Sunday, June 5 at 4:30 p.m. |
|
Stephanie L. Goff, M.D. |
Monday, June 6 at 9:45 a.m. |
|
|
COVID-19 and Cancer: Advantages and Disadvantages of Immunotherapy |
Elad Sharon, M.D., M.P.H. |
Monday, June 6 at 11:30 a.m. |
|
Kishan Pithadia, B.S. |
Monday, June 6 at 11:30 a.m. |
|
|
Louis M. Staudt, M.D., Ph.D. |
Monday, June 6 at 3:00 p.m. |
|
|
Todd M. Gibson, Ph.D. | Monday, June 6 at 3:00 p.m. |
NCI Exhibit Booth #4043
NCI staff were available at the NCI exhibit booth (#4043) to answer questions about NCI programs, resources, training, and opportunities.